Invitae (NYSE:NVTA) Earns Hold Rating from Analysts at Stock

Stock analysts at StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, The Goldman Sachs Group lowered their target price on Invitae from $1.00 to $0.50 and set a “sell” rating on […]

Related Keywords

Canada , Blackrock , Nova Scotia , United States , , Investment Management , Invitae Company Profile , Goldman Sachs Group , Invitae Corporation , Geode Capital Management , Vanguard Group Inc , Blackrock Inc , Goldman Sachs Group Inc , Get Free Report , Capital Management , Sachs Group , Invitae Daily , Invitae , Nyse Nvta , Nvta , Medical , Initiated Coverage , Stocknews Com ,